AQUINOX PHARMACEUTICALS INC's ticker is AQXP and the CUSIP is 03842B101. A total of 47 filers reported holding AQUINOX PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,465,000 | -74.0% | 500,000 | +25.0% | 0.31% | -72.7% |
| Q1 2018 | $5,632,000 | +19.7% | 400,000 | 0.0% | 1.14% | +3.3% |
| Q4 2017 | $4,704,000 | -17.1% | 400,000 | 0.0% | 1.10% | -8.5% |
| Q3 2017 | $5,676,000 | +34.5% | 400,000 | +33.3% | 1.20% | +37.4% |
| Q2 2017 | $4,221,000 | +12.4% | 300,000 | +33.3% | 0.88% | +25.3% |
| Q1 2017 | $3,755,000 | +1.1% | 225,000 | 0.0% | 0.70% | -21.7% |
| Q4 2016 | $3,715,000 | +11.2% | 225,000 | -10.0% | 0.89% | +64.9% |
| Q3 2016 | $3,340,000 | – | 250,000 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 877,753 | $11,727,000 | 5.26% |
| RA Capital Management | 2,191,977 | $29,285,000 | 3.02% |
| NEXTHERA CAPITAL LP | 340,000 | $4,542,000 | 2.79% |
| Opaleye Management Inc. | 310,000 | $4,142,000 | 2.17% |
| Baker Brothers Advisors | 10,536,092 | $140,762,000 | 1.28% |
| Ghost Tree Capital, LLC | 250,000 | $3,340,000 | 0.54% |
| Cormorant Asset Management, LP | 151,838 | $2,029,000 | 0.22% |
| DAFNA Capital Management LLC | 20,000 | $267,000 | 0.19% |
| ELLINGTON MANAGEMENT GROUP LLC | 10,800 | $144,000 | 0.04% |
| Alyeska Investment Group, L.P. | 272,163 | $3,636,000 | 0.03% |